William W. Crouse

Mr. Crouse is a retired Managing General Partner of Healthcare Ventures, which led the strategic development and management of more than 100 companies with a combined market capitalization exceeding $60 billion. Examples of HealthCare Ventures companies include Human Genome Sciences, MedImmune (acquired by Astra Zeneca), Novazyme (acquired by Genzyme), Shire, Dendreon, and FoldRx, (acquired by Pfizer). Prior to joining HealthCare Ventures, he was Worldwide President of Ortho Diagnostic Systems and a Vice President of Johnson & Johnson International from 1987 to 1993. He currently serves on the Board of Directors for The Medicines Company, and 3 private biotech companies. He also serves as an Advisory Board Member of Windham Venture Partners.